|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1455 PENNSYLVANIA AVENUE, NW |
Address2 | SUITE 925 |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 66716-12
|
||||||||
|
6. House ID# 355670000
|
TYPE OF REPORT | 8. Year | 2015 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Steven LaPierre |
Date | 1/19/2016 4:16:50 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
S. 149 - Medical Device Access & Innovation Protection Act - A bill to repeal the 2.3% medical device tax
H.R. 160 - Protect Medical Innovation Act of 2015 - A bill to repeal the 2.3% medical device tax
Comprehensive/Corporate Tax Reform W&M Discussion Draft - Includes lower corporate tax rate, research credit transition, and base erosion
Senate Finance Tax Reform Discussion Draft - International Tax Reform Provisions - Tax Extender Provisions
H.R. 880 - Research and Development tax credit extension
H.R. 2029PATH Act - Permanent Tax Extender Package + 2 year Suspension of Medical Device Tax
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brenda |
Becker |
|
|
|
Steven |
LaPierre |
|
|
|
Christopher |
Timmerman |
|
|
|
Issac |
Fordjour |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Public Law 112-144 - Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) specifically pertaining to user fees used to train FDA staff and streamline approval process
Unique Device Identifiers (UDI) - Implementation of UDI rule
H.R. 6 - 21st Century Cures Initiative - Legislation to accelerate the pace of biomedical innovation and cures by modernizing federal research and regulatory agencies
Innovation for Healthier Americans (Senate, companion) - Legislation to accelerate the pace of biomedical innovation and cures by modernizing federal research and regulatory agencies
FDA/CMS Breakthrough Pathway - Legislation to harmonize CMS Reimbursement with FDA Approval to speed products' market introduction
Heroin & Prescription Opioid Abuse, Prevention, Education, Enforcement Act
H.R. 2805 - Multi Agency legislation to establish a task force to develop and study for pain management and prescription of pain medication
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brenda |
Becker |
|
|
|
Steven |
LaPierre |
|
|
|
Isaac |
Fordjour |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Public Law No 113-6 - CONSOLIDATED AND FURTHER CONTINUING APPROPRIATIONS ACT, 2013 - Specifically, have been working on relief of 5% sequestration of FDA CDRH User Fees
Public Law No: 113-67 - Making continuing appropriations for fiscal year 2014, and for other purposes. Specifically provisions providing appropriations for the FDAs CDRH evaluation of medical technology.
FY 2016 Agriculture Appropriations Bill (House) - FDA Funding
FY 2016 Agriculture Appropriations Bill (Senate) - FDA Funding
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steven |
LaPierre |
|
|
|
Christopher |
Timmerman |
|
|
|
Isaac |
Fordjour |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPI
16. Specific lobbying issues
H.R. 234 - Cyber Intelligence Sharing & Protection Act (CISPA) - A bill to promote industry and government sharing of cyber intelligence
H.R. 85 / H.R. 1073 - Critical Infrastructure Protection Acts - Bills to make improvements regarding cyber security and critical infrastructure protection
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brenda |
Becker |
|
|
|
Steven |
LaPierre |
|
|
|
Christopher |
Timmerman |
|
|
|
Isaac |
Fordjour |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
H.R. 9 - Innovation Act - Comprehensive Patent Reform - a bill to address the problem of abusive patent litigation
H.R. 2045 - Targeting Rogue and Opaque Letters Act (TROL Act) - Increases transparency and accountability in patent demand letters and provides Federal Trade Commission (FTC) with the authority to levy fines on those who send deceptive demand letters
Leahy, Schumer, Grassley, Cornyn Draft - Yet to be released legislation for comprehensive patent reform.
H.R. 3326 Defend Trade Secrets Act - legislation to establish a Federal Civil cause of action for Trade Secret Misappropriation
S.632 - The STRONG Patents Act of 2015: Support Technology & Research for Our Nations Growth - a bill to end frivolous patent lawsuits.
Copyright Office Petition - Oppose third party researchers to access technology and software inside medical devices.
S. 1137 - Patent Act - A Bill to Reform U.S. Patent Litigation
S. 1890/ H.R.3226 - Bills to create a federal civil cause of action for Trade Secret misappropriation
S. 1890 - Defend Trade Secrets Act - legislation to establish a Federal Civil cause of action for Trade Secret Misappropriation
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steven |
LaPierre |
|
|
|
Christopher |
Timmerman |
|
|
|
Brenda |
Becker |
|
|
|
Isaac |
Fordjour |
|
|
|
Paul |
Barry |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
VHA Directive 2009-053 - Pain care directive - working to increase veteran access to pain specialists and FDA approved alternative treatments in the VHA.
Public Law No 113-146 - Veterans Access, Choice, and Accountability Act: Implementation of law to allow veterans to seek healthcare from non-VA facilities if unable to receive care from the VA in a timely manner.
VA Vendor Credentialing - Proposals to establish a national credentialing system for VA
National Pain Strategy - Encouraging adaption of the NIH's National Pain Strategy
H.R. 4063 - Promise Act - Legislation to improve quality of Pain Care provided to Veterans Brooks Bill - H.R. 2805 (HCR)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brenda |
Becker |
|
|
|
Steven |
LaPierre |
|
|
|
Christopher |
Timmerman |
|
|
|
Isaac |
Fordjour |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Trade Promotion Authority (TPA) - Supporting passage of authority to expedite pending and future trade agreements, such as TPP
Transpacific Partnership (TPP) - Supporting passage for greater regulatory harmonization across Asia-Pacific country members and to include transparency and procedural fairness provisions in the agreement.
Transatlantic Trade & Investment Partnership (T-TIP) - Supporting passage for greater regulatory harmonization of product approvals and registration
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Barry |
|
|
|
Steven |
LaPierre |
|
|
|
Isaac |
Fordjour |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1020 - STEM Education Act of 2015 (Smith). Bill to increase STEM Education
H.R. 840 - STEM Gateways Act (Kennedy). Bill to increase STEM Education
S. 402 - STEM Master Teacher Corps Act of 2015 (Franken). Bill to increase STEM Education
S. 442 - Innovation Inspiration School Grant Program Act (Shaheen). Bill to increase STEM Education
S. 1177 ESEA Bill, Specifically Provisions to provide more funding and access to after school STEM Programs
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steven |
LaPierre |
|
|
|
Isaac |
Fordjour |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
FAA Re authorization - Limitations on aircraft transportation of lithium batteries
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steven |
LaPierre |
|
|
|
Brenda |
Becker |
|
|
|
Isaac |
Fordjour |
|
|
|
Christopher |
Timmerman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |